Psoriasis and beyond: targeting the IL-17 pathway
Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, and new insights into the immune processes have thrown up a number of exciting drug targets. This Nature Reviews Drug Discovery animation explores how the immune system goes awry in psoriasis and illustrates how agents that target the cytokine interleukin 17, or other players in the same pathway, are being developed into novel therapies for psoriasis.
Видео Psoriasis and beyond: targeting the IL-17 pathway канала nature video
Видео Psoriasis and beyond: targeting the IL-17 pathway канала nature video
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Psoriatic ArthritisPsoriasisImmunology in the skinPsoriasis, Causes, Types, Sign and Symptoms, Diagnosis and Treatment.Understanding PsoriasisHealing Psoriasis From The Inside Out with Dr. Todd LePinePsoriatic Arthritis - 3D Medical AnimationInnate lymphoid cellsImmunology in the Gut MucosaPsoriasis Data Review and Safety RecommendationsMy Body Is 90% Covered In Psoriasis | TRULYTreating scalp psoriasisMedicine for members: Psoriasis and psoriatic arthritisPsoriasis: Causes, treatment and controlTumour immunology and immunotherapyHow do monoclonal antibodies work? Rituximab, infliximab, adalimumab and othersHomeless Man Has Psoriasis: He Can’t Shower/Lie Down Due to His Skin Flakes8 Foods That Affect PsoriasisImmunology of the rheumatoid jointWhat is Psoriasis? Definition, Etiology, Classification, Pathophysiology, Diagnosis, Treatment